Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

BS Mitchell, E Mejias, PE Daddona… - Proceedings of the …, 1978 - National Acad Sciences
BS Mitchell, E Mejias, PE Daddona, WN Kelley
Proceedings of the National Academy of Sciences, 1978National Acad Sciences
Deoxyadenosine at low concentrations and in the presence of an inhibitor of adenosine
deaminase (adenosine aminohydrolase, EC 3.5. 4.4) is markedly toxic to lymphoblast cell
lines of T cell origin but does not impair growth of B cell lines. Deoxyguanosine is also more
toxic for T lymphoblasts. In the presence of deoxyadenosine or deoxyguanosine, elevation
of the corresponding deoxyribonucleoside triphosphate (dATP or dGTP) occurs in T cell, but
not in B cell, lines. The addition of deoxycytidine or dipyridamole results in lower dATP and …
Deoxyadenosine at low concentrations and in the presence of an inhibitor of adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) is markedly toxic to lymphoblast cell lines of T cell origin but does not impair growth of B cell lines. Deoxyguanosine is also more toxic for T lymphoblasts. In the presence of deoxyadenosine or deoxyguanosine, elevation of the corresponding deoxyribonucleoside triphosphate (dATP or dGTP) occurs in T cell, but not in B cell, lines. The addition of deoxycytidine or dipyridamole results in lower dATP and dGTP levels and prevents deoxyribonucleoside toxicity. These findings provide a molecular basis for the immunodeficiency observed in individuals with several inborn errors of purine metabolism.
National Acad Sciences